Signal Quality Investigation of a New Wearable Frontal Lobe EEG Device

Conductive Hydrogel Tapes for Tripolar EEG: A Promising Solution to Paste-Related Challenges

Electroencephalography (EEG) remains pivotal in neuroscience for its non-invasive exploration of brain activity, yet traditional electrodes are plagued with artifacts and the application of conductive paste poses practical challenges. Tripolar concentric ring electrode (TCRE) sensors used for EEG (tEEG) attenuate artifacts automatically, improving the signal quality. Hydrogel tapes offer a promising alternative to conductive paste, providing mess-free application and reliable electrode-skin contact in locations without hair. Since the electrodes of the TCRE sensors are only 1.0 mm apart, the impedance of the skin-to-electrode impedance-matching medium is critical. This study evaluates four hydrogel tapes' efficacies in EEG electrode application, comparing impedance and alpha wave characteristics. Healthy adult participants underwent tEEG recordings using different tapes. The results highlight varying impedances and successful alpha wave detection despite increased tape-induced impedance. MATLAB's EEGLab facilitated signal processing. This study underscores hydrogel tapes' potential as a convenient and effective alternative to traditional paste, enriching tEEG research methodologies. Two of the conductive hydrogel tapes had significantly higher alpha wave power than the other tapes, but were never significantly lower.

Remote Wearable Neuroimaging Devices for Health Monitoring and Neurophenotyping: A Scoping Review

Digital health tracking is a source of valuable insights for public health research and consumer health technology. The brain is the most complex organ, containing information about psychophysical and physiological biomarkers that correlate with health. Specifically, recent developments in electroencephalogram (EEG), functional near-infra-red spectroscopy (fNIRS), and photoplethysmography (PPG) technologies have allowed the development of devices that can remotely monitor changes in brain activity. The inclusion criteria for the papers in this review encompassed studies on self-applied, remote, non-invasive neuroimaging techniques (EEG, fNIRS, or PPG) within healthcare applications. A total of 23 papers were reviewed, comprising 17 on using EEGs for remote monitoring and 6 on neurofeedback interventions, while no papers were found related to fNIRS and PPG. This review reveals that previous studies have leveraged mobile EEG devices for remote monitoring across the mental health, neurological, and sleep domains, as well as for delivering neurofeedback interventions. With headsets and ear-EEG devices being the most common, studies found mobile devices feasible for implementation in study protocols while providing reliable signal quality. Moderate to substantial agreement overall between remote and clinical-grade EEGs was found using statistical tests. The results highlight the promise of portable brain-imaging devices with regard to continuously evaluating patients in natural settings, though further validation and usability enhancements are needed as this technology develops.

[Applications and challenges of wearable electroencephalogram signals in depression recognition and personalized music intervention]

Rapid and accurate identification and effective non-drug intervention are the worldwide challenges in the field of depression. Electroencephalogram (EEG) signals contain rich quantitative markers of depression, but whole-brain EEG signals acquisition process is too complicated to be applied on a large-scale population. Based on the wearable frontal lobe EEG monitoring device developed by the authors' laboratory, this study discussed the application of wearable EEG signal in depression recognition and intervention. The technical principle of wearable EEG signals monitoring device and the commonly used wearable EEG devices were introduced. Key technologies for wearable EEG signals-based depression recognition and the existing technical limitations were reviewed and discussed. Finally, a closed-loop brain-computer music interface system for personalized depression intervention was proposed, and the technical challenges were further discussed. This review paper may contribute to the transformation of relevant theories and technologies from basic research to application, and further advance the process of depression screening and personalized intervention.

Automatic sleep staging by a hybrid model based on deep 1D-ResNet-SE and LSTM with single-channel raw EEG signals

Sleep staging is crucial for assessing sleep quality and diagnosing sleep disorders. Recent advances in deep learning methods with electroencephalogram (EEG) signals have shown remarkable success in automatic sleep staging. However, the use of deeper neural networks may lead to the issues of gradient disappearance and explosion, while the non-stationary nature and low signal-to-noise ratio of EEG signals can negatively impact feature representation. To overcome these challenges, we proposed a novel lightweight sequence-to-sequence deep learning model, 1D-ResNet-SE-LSTM, to classify sleep stages into five classes using single-channel raw EEG signals. Our proposed model consists of two main components: a one-dimensional residual convolutional neural network with a squeeze-and-excitation module to extract and reweight features from EEG signals, and a long short-term memory network to capture the transition rules among sleep stages. In addition, we applied the weighted cross-entropy loss function to alleviate the class imbalance problem. We evaluated the performance of our model on two publicly available datasets; Sleep-EDF Expanded consists of 153 overnight PSG recordings collected from 78 healthy subjects and ISRUC-Sleep includes 100 PSG recordings collected from 100 subjects diagnosed with various sleep disorders, and obtained an overall accuracy rate of 86.39% and 81.97%, respectively, along with corresponding macro average F1-scores of 81.95% and 79.94%. Our model outperforms existing sleep staging models in terms of overall performance metrics and per-class F1-scores for several sleep stages, particularly for the N1 stage, where it achieves F1-scores of 59.00% and 55.53%. The kappa coefficient is 0.812 and 0.766 for the Sleep-EDF Expanded and ISRUC-Sleep datasets, respectively, indicating strong agreement with certified sleep experts. We also investigated the effect of different weight coefficient combinations and sequence lengths of EEG epochs used as input to the model on its performance. Furthermore, the ablation study was conducted to evaluate the contribution of each component to the model's performance. The results demonstrate the effectiveness and robustness of the proposed model in classifying sleep stages, and highlights its potential to reduce human clinicians' workload, making sleep assessment and diagnosis more effective. However, the proposed model is subject to several limitations. Firstly, the model is a sequence-to-sequence network, which requires input sequences of EEG epochs. Secondly, the weight coefficients in the loss function could be further optimized to balance the classification performance of each sleep stage. Finally, apart from the channel attention mechanism, incorporating more advanced attention mechanisms could enhance the model's effectiveness.

Assessment of a 16-Channel Ambulatory Dry Electrode EEG for Remote Monitoring

Ambulatory EEGs began emerging in the healthcare industry over the years, setting a new norm for long-term monitoring services. The present devices in the market are neither meant for remote monitoring due to their technical complexity nor for meeting clinical setting needs in epilepsy patient monitoring. In this paper, we propose an ambulatory EEG device, OptiEEG, that has low setup complexity, for the remote EEG monitoring of epilepsy patients. OptiEEG's signal quality was compared with a gold standard clinical device, Natus. The experiment between OptiEEG and Natus included three different tests: eye open/close (EOC); hyperventilation (HV); and photic stimulation (PS). Statistical and wavelet analysis of retrieved data were presented when evaluating the performance of OptiEEG. The SNR and PSNR of OptiEEG were slightly lower than Natus, but within an acceptable bound. The standard deviations of MSE for both devices were almost in a similar range for the three tests. The frequency band energy analysis is consistent between the two devices. A rhythmic slowdown of theta and delta was observed in HV, whereas photic driving was observed during PS in both devices. The results validated the performance of OptiEEG as an acceptable EEG device for remote monitoring away from clinical environments.

EEG Signals Based Internet Addiction Diagnosis Using Convolutional Neural Networks

Internet addiction (IA), as a new and often unrecognized psychosocial disorder, endangers people’s health and their lives. However, the common biometric analysis based on the combination of EEG signals and results of questionnaires is not quantitative, and thus difficult to ensure a specific biomarker. This work aims to develop a deep learning algorithm (no need to identify biomarkers) used for diagnosing IA and evaluating therapy efficacy. Herein, a five-layer CNN model combined with a fast Fourier transform is proposed to diagnose IA quantitatively. This algorithm is validated in the Lemon dataset by using it to process raw data, full spectral power, and alpha-beta-gamma spectral power (related to IA). In contrast to alpha-beta-gamma spectral power, the results based on full spectral power show better performance (87.59% accuracy, 88.80% sensitivity, and 86.41% specificity), which confirms that the proposed algorithm can diagnose IA without biomarkers. In addition, this proposed CNN model presents obvious advantages in processing raw data, achieving 81.1% accuracy. Such results verify that this method can contribute to the reduction of diagnosis time and be potentially used in real-time health monitoring systems. This work provides a quantitative approach to diagnose IA and evaluate therapy efficacy, as a general strategy, and can be widely used in other disorder diagnoses that affect EEG signals, such as psychiatric disorders, substance dependence, and depression.